文献速递主动脉疾病

大直径主动脉腔内移植物与动脉瘤囊扩张相关

"Large Diameter" Aortic Endografts are Associated With Aneurysm Sac Expansion.
PubMed 文献 · Ann Vasc Surg · 2022-05-17

该回顾性研究纳入2000至2018年按说明书使用(on-IFU)行EVAR的连续患者1099例(980例有随访数据),比较>34 mm与≤34 mm移植物长期结局,发现大直径移植物与随访期间囊扩张率更高相关(P=0.038),再干预、开放转换或破裂无显著差异。

要点

  • >34 mm大直径移植物组术后囊扩张率高于≤34 mm组(P=0.038)。
  • 两组再干预率、开放转换率及破裂率无显著差异。
  • 多因素分析显示年龄、术前AAA直径、再干预及>34 mm移植物为囊扩张独立相关因素。

核心结论

  • 使用大直径主动脉腔内移植物与长期随访期间囊扩张率更高相关。
  • 大直径移植物在部分患者中无疑有使用价值,但需认识到这类器械通常是在上市后获批,未经历与小直径移植物相同的监管审查。
  • 这些发现强调了对>34 mm移植物治疗患者进行持续监测的重要性,无论其是否符合厂商说明书。

研究设计与样本

  • 回顾性综述,纳入2000至2018年连续接受on-IFU EVAR的患者,按器械直径进行长期结局比较分析。
  • 共1099例接受on-IFU EVAR,980例有随访数据,其中75例(7.6%)使用>34 mm器械。
  • 大直径器械定义为>34 mm。
  • 主要结局为长期随访期间无囊扩张生存。
  • 分析包括标准双变量分析、Kaplan-Meier及log-rank比较、Cox比例风险多因素分析。

主要发现

  • 两组人口学特征及合并症无显著差异,但>34 mm器械组术前腹主动脉瘤直径更大(58 ± 8.5 mm vs. 56 ± 17.4 mm;P = 0.05)。
  • 中位随访10.3年。
  • >34 mm移植物组随访期间无囊扩张生存率降低(P = 0.038)。
  • 按移植物直径分层,再干预率、开放转换或破裂无显著差异。
  • 多因素Cox回归识别患者年龄、术前腹主动脉瘤直径、需再干预及使用>34 mm腔内移植物为与囊扩张相关的独立因素。

临床怎么用

  • 作者认为,这些发现强调了对>34 mm移植物治疗患者进行持续监测的重要性,无论其是否符合厂商说明书。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The purpose of this study was to evaluate the association between aortic endograft diameter and long-term outcomes following endovascular aneurysm repair (EVAR) performed in accordance with manufacturer instructions for use (IFU). METHODS: A retrospective review of consecutive patients undergoing on-IFU EVAR (2000-2018) was performed to facilitate a comparative analysis of long-term patient outcomes based on device diameter. "Large diameter" devices were defined as >34 mm. The primary outcome of interest was freedom from sac expansion throughout long-term follow-up. Analyses included standard bivariate analyses, Kaplan-Meier with log-rank comparison, and Cox proportional hazards multivariate analysis. RESULTS: A total of 1,099 underwent on-IFU EVAR from 2000-2018. Follow-up data were available for 980 patients. Of these, 75 patients (7.6%) were treated with >34-mm devices. There were no significant differences in demographics or comorbidities between the 2 groups, although preoperative abdominal aortic aneurysm size was greater in patients undergoing implantation of >34-mm devices (58 ± 8.5 mm vs. 56 ± 17.4 mm; P = 0.05). Median follow-up was 10.3 years. Patients with grafts >34 mm had reduced freedom from sac expansion throughout follow-up (P = 0.038). There were no significant differences in reintervention rates, open conversion, or rupture when stratified by graft diameter. A multivariate Cox regression identified patient age, preoperative abdominal aortic aneurysm size, need for reintervention, and use of >34-mm endografts as independent factors associated with expansion. CONCLUSIONS: The use of large diameter aortic endografts is associated with higher rates of sac expansion during long-term follow-up. Although there is undoubtedly a role for large diameter graft use in selected patients, it is important to recognize that these devices were typically approved post hoc without the same regulatory scrutiny of smaller endografts. These findings underscore the importance of ongoing surveillance for patients treated with >34-mm grafts, irrespective of compliance with manufacturer IFU.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Lu PG, Erben Y, Sheaffer WW, et al. "Large Diameter" Aortic Endografts are Associated With Aneurysm Sac Expansion. Ann Vasc Surg. 2022. PMID: 35595204. doi:10.1016/j.avsg.2022.04.046

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。